[Federal Register Volume 73, Number 61 (Friday, March 28, 2008)]
[Notices]
[Page 16711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-6391]



[[Page 16711]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated November 19, 2007 and published in the Federal 
Register on November 30, 2007, (72 FR 67758-67759), Clinical Supplies 
Management, Inc., 4733 Amber Valley Parkway, Fargo, North Dakota 58104, 
made application to the Drug Enforcement Administration (DEA) to be 
registered as an importer of Sufentanil (9740), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
clinical trials, research, and analytical purposes. The company has 
withdrawn its request for schedule I Tetrahydrocannabinols (7370).
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Clinical Supplies Management, Inc. to import the basic 
class of controlled substance is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Clinical Supplies Management, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with State and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-6391 Filed 3-27-08; 8:45 am]
BILLING CODE 4410-09-P